Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 μM, respectively). Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 μM).
Description | Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 μM, respectively). Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 μM). |
Targets&IC50 | rP2X3:0.87 μM, 5-HT2A Receptor:1.3 μM, GlyT2:0.86 μM |
Molecular Weight | 394.51 |
Formula | C21H34N2O5 |
CAS No. | 1441000-45-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Opiranserin 1441000-45-8 G蛋白偶联受体 离子通道 神经科学 5-HT Receptor GlyT P2 Receptor P2X Receptor Glycine transporters postoperative VVZ-149 Serotonin Receptor 5-hydroxytryptamine Receptor VVZ 149 pain Inhibitor non-opioid P2XRs anti-inflammatory VVZ149 analgesic inhibit inhibitor